Latest stories on ACAD
ACADIA PHARMACEUTICALS INC (ACAD) files 8-K
SEC 8-K50 · neutralgeneral
Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026
StockTitan50 · neutralgeneral
Acadia Pharmaceuticals downgraded to Neutral from Buy at UBS
The Fly34 · bearishanalyst
Acadia Pharmaceuticals price target lowered to $36 from $37 at RBC Capital
The Fly38 · neutralanalyst
Acadia, Zydus patent litigation case looks resolved, says RBC
Seeking Alpha63 · neutralgeneral
RBC Capital reiterates Acadia Pharmaceuticals stock rating on patent developments
Investing.com Analyst Ratings56 · neutralanalyst
Why is ACADIA Pharmaceuticals stock climbing today?
Investing.com Markets50 · neutralgeneral
Acadia looks to have settled case with Zydus, says RBC Capital
The Fly56 · neutralgeneral
Acadia Pharmaceuticals announces USPTO allowance of patent covering Trofinetide
The Fly63 · neutralproduct/pr
Acadia Pharmaceuticals drops 7%, continuing fall after drug trial results
Seeking Alpha32 · bearishearnings
ACAD Stock Tumbles Today: Analysts Weigh RADIANT Results, Cut Price Targets
Stocktwits News38 · neutralanalyst
Acadia price target lowered to $33 from $37 at H.C. Wainwright
The Fly38 · neutralanalyst
Acadia Pharmaceuticals price target lowered to $35 from $41 at Needham
The Fly34 · bearishanalyst
Acadia Pharmaceuticals price target lowered to $31 from $38 at Deutsche Bank
The Fly34 · bearishanalyst
Needham cuts Acadia Pharmaceuticals stock price target on trial results
Investing.com Analyst Ratings34 · bearishanalyst
Acadia Pharmaceuticals price target lowered to $34 from $36 at BMO Capital
The Fly38 · neutralanalyst
Air Canada expects to buy back about C$800M in shares
Seeking Alpha71 · bullishgeneral
Acadia Pharmaceuticals price target lowered to $33 from $36 at Citizens
The Fly38 · neutralanalyst
Citizens cuts Acadia Pharmaceuticals stock price target on trial miss
Investing.com Analyst Ratings34 · bearishanalyst
ACAD Stock Clocks Worst Day In 2 Years After Alzheimer’s Psychosis Drug Misses Main Goal — Citi Cuts Drug’s Success Odds To 20%
Stocktwits News28 · bearishearnings
Acadia Reports Phase 2 Data for Alzheimer’s Psychosis
TipRanks59 · neutralproduct/pr
ACADIA PHARMACEUTICALS INC (ACAD) files 8-K
SEC 8-K50 · neutralgeneral
Air Canada eyes Ho Chi Minh City route as Canada-Vietnam ties grow
Seeking Alpha58 · neutralproduct/pr
Goldman Sachs reiterates Acadia Pharmaceuticals stock Sell rating after trial miss
Investing.com Analyst Ratings32 · bearishanalyst